Extens completes a strategic merger to build Ubaq

Back Published on 15/06/2023

Extens supports Clardian in its merger with Qairn to create a European leader in PharmTech.

PharmTech specialists Qairn and Clardian have joined forces to become Ubaq: the first dematerialised regulatory process solution for the healthcare industry. 

The merger of Clardian and Qairn comes from the desire to combine the strengths of two complementary structures to create a new major European player in the dematerialisation of regulatory processes in the healthcare industry.

Clardian, an Extens portfolio company since 2021, is a long-standing player in the software market dedicated to compliance and the optimisation of regulatory processes for the healthcare industry. With more than 15 years of experience, it benefits from recognised expertise and a portfolio of loyal clients in France and abroad.

More oriented towards SMEs in the healthcare sector, Qairn, created in 2021, has developed a cutting-edge technology based on efficient, ergonomic and easily adaptable tools that have enabled it to quickly take position in the market.
« Ubaq combines the best of both worlds: the credibility, regulatory expertise and international presence of a historical player in the sector with the agility, dynamism and technological performance of a young company. These assets should enable Ubaq to establish itself as a major European player in PharmTech by putting innovation at the service of healthcare players. »